Exact Sciences
EXAS
#1148
Rank
NZ$35.86 B
Marketcap
NZ$187.89
Share price
0.00%
Change (1 day)
96.48%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): NZ-$2.53

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is NZ-$9.53. In 2022 the company made an earnings per share (EPS) of NZ-$6.34 a decrease over its 2021 EPS that were of NZ-$6.20.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$2.53-60.08%
2022NZ-$6.342.31%
2021NZ-$6.20-37.09%
2020NZ-$9.85674.65%
2019NZ-$1.27-50.69%
2018NZ-$2.5844%
2017NZ-$1.79-39.39%
2016NZ-$2.96-2.94%
2015NZ-$3.0437.1%
2014NZ-$2.2279.71%
2013NZ-$1.24-21.59%
2012NZ-$1.5862.96%
2011NZ-$0.9792.86%
2010NZ-$0.50-3.45%
2009NZ-$0.52-19.44%
2008NZ-$0.64-18.18%
2007NZ-$0.79-10.2%
2006NZ-$0.88-10.91%
2005NZ-$0.99-24.66%
2004NZ-$1.31-51.33%
2003NZ-$2.69-7.41%
2002NZ-$2.9011.72%
2001NZ-$2.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
NZ$3.41-135.77%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
NZ$2.58-127.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.61-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$2.13-77.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ-$91.16 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA